Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

SEC Subpoenas Biomet for Potential FCPA Violations

Jaclyn Jaeger | July 7, 2014

BioMet said in a filing with the Securities and Exchange Commission last week that the SEC issued the medical device maker a subpoena requiring that the company produce certain documents relating to possible violations of the Foreign Corrupt Practices Act.

BioMet said in a Form 8-K that it received a subpoena on July 2, 2014, from the SEC, seeking “certain documents” related to potential FCPA violations regarding its operations in Brazil and Mexico, which Biomet became aware of in October 2013.

Under the terms of a three-year deferred prosecution agreement reached with the Department of Justice in March 2012, Biomet disclosed these matters to the independent compliance monitor, as well as to the government.  Under that DPA, Biomet was saddled with a compliance...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.